Publications (46) Susana Mato Santos publications

filter_list

2025

  1. Functional differentiation of human dental pulp stem cells into neuron-like cells exhibiting electrophysiological activity

    Stem cell research & therapy, Vol. 16, Núm. 1, pp. 10

  2. In Vivo Assessment of Cortical Astrocyte Network Dysfunction During Autoimmune Demyelination: Correlation With Disease Severity

    Journal of Neurochemistry, Vol. 169, Núm. 2

2024

  1. Autoimmune inflammation triggers aberrant astrocytic calcium signaling to impair synaptic plasticity

    Brain, Behavior, and Immunity, Vol. 121, pp. 192-210

  2. CB1 receptors in NG2 cells mediate cannabinoid-evoked functional myelin regeneration

    Progress in Neurobiology, Vol. 243

  3. Konposatu kannabinoideak terapia gehigarri gisa esklerosi anizkoitzaren tratamendurako: Cannabinoid-based add on therapies for multiple sclerosis treatment

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 46, pp. 297-313

2023

  1. Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells

    GLIA, Vol. 71, Núm. 1, pp. 103-126

  2. Refinement of human dental pulp stem cell neurodifferentiation protocols into functional neural like cells

    IBRO Neuroscience Reports, Vol. 15, Núm. Supl. 1, pp. S195

  3. Spatial organization of neuron-astrocyte interactions in the somatosensory cortex

    Cerebral cortex (New York, N.Y. : 1991), Vol. 33, Núm. 8, pp. 4498-4511

  4. The endocannabinoid system and autoimmune demyelination: A focus on multiple sclerosis

    Neurobiology and Physiology of the Endocannabinoid System (Elsevier), pp. 229-240

2022

  1. Cannabinoid CB1 receptor expression in oligodendrocyte progenitors of the hippocampus revealed by the NG2-EYFP-knockin mouse

    Frontiers in Neuroanatomy, Vol. 16

  2. Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice

    Cell Death and Disease, Vol. 13, Núm. 7

2021

  1. Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation

    npj Parkinson's Disease, Vol. 7, Núm. 1

  2. CB1 Hartzaile kanabinoidearen azalpena saguaren garuneko zelula oligodendroglialetan

    Osasun zientzak: IV. Ikergazte Nazioarteko Ikerteta Euskaraz. 2021eko ekainaren 9, 10 eta . Gasteiz, Euskal Herria.

  3. Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1

    Histochemistry and Cell Biology, Vol. 156, Núm. 5, pp. 479-502

  4. Δ9-Tetrahydrocannabinol promotes functional remyelination in the mouse brain

    British Journal of Pharmacology, Vol. 178, Núm. 20, pp. 4176-4192

  5. Δ9-Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo

    GLIA, Vol. 69, Núm. 3, pp. 532-545

2020

  1. ABHD6-aren inhibizioaren azterketa birmielinizazioa bultzatzeko kuprizonaren desmielinizazio primarioaren aniamalia-ereduan.

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 38, pp. 241-257

  2. Gene expression analysis of astrocyte and microglia endocannabinoid signaling during autoimmune demyelination

    Biomolecules, Vol. 10, Núm. 9, pp. 1-19

  3. P2X7 Receptor-Dependent Layer-Specific Changes in Neuron-Microglia Reactivity in the Prefrontal Cortex of a Phencyclidine Induced Mouse Model of Schizophrenia

    Frontiers in Molecular Neuroscience, Vol. 13

  4. P2x7 receptors control demyelination and inflammation in the cuprizone model

    Brain, Behavior, and Immunity - Health, Vol. 4